Literature DB >> 25367532

Variability in ADHD care in community-based pediatrics.

Jeffery N Epstein1, Kelly J Kelleher2, Rebecca Baum2, William B Brinkman3, James Peugh3, William Gardner4, Phil Lichtenstein5, Joshua Langberg6.   

Abstract

BACKGROUND: Although many efforts have been made to improve the quality of care delivered to children with attention-deficit/hyperactivity disorder (ADHD) in community-based pediatric settings, little is known about typical ADHD care in these settings other than rates garnered through pediatrician self-report.
METHODS: Rates of evidence-based ADHD care and sources of variability (practice-level, pediatrician-level, patient-level) were determined by chart reviews of a random sample of 1594 patient charts across 188 pediatricians at 50 different practices. In addition, the associations of Medicaid-status and practice setting (ie, urban, suburban, and rural) with the quality of ADHD care were examined.
RESULTS: Parent- and teacher-rating scales were used during ADHD assessment with approximately half of patients. The use of Diagnostic and Statistical Manual of Mental Disorders criteria was documented in 70.4% of patients. The vast majority (93.4%) of patients with ADHD were receiving medication and only 13.0% were receiving psychosocial treatment. Parent- and teacher-ratings were rarely collected to monitor treatment response or side effects. Further, fewer than half (47.4%) of children prescribed medication had contact with their pediatrician within the first month of prescribing. Most variability in pediatrician-delivered ADHD care was accounted for at the patient level; however, pediatricians and practices also accounted for significant variability on specific ADHD care behaviors.
CONCLUSIONS: There is great need to improve the quality of ADHD care received by children in community-based pediatric settings. Improvements will likely require systematic interventions at the practice and policy levels to promote change.
Copyright © 2014 by the American Academy of Pediatrics.

Entities:  

Keywords:  attention deficit and disruptive behavior disorders; behavioral medicine; guidelines; pediatrics; quality

Mesh:

Substances:

Year:  2014        PMID: 25367532      PMCID: PMC4243070          DOI: 10.1542/peds.2014-1500

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  30 in total

Review 1.  Hidden morbidity in pediatric primary care.

Authors:  Pilar Bernal
Journal:  Pediatr Ann       Date:  2003-06       Impact factor: 1.132

Review 2.  Use, quality, and outcomes of care for mental health: the rural perspective.

Authors:  Kathryn Rost; John Fortney; Ellen Fischer; Jeffrey Smith
Journal:  Med Care Res Rev       Date:  2002-09       Impact factor: 3.929

3.  ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents.

Authors:  Mark Wolraich; Lawrence Brown; Ronald T Brown; George DuPaul; Marian Earls; Heidi M Feldman; Theodore G Ganiats; Beth Kaplanek; Bruce Meyer; James Perrin; Karen Pierce; Michael Reiff; Martin T Stein; Susanna Visser
Journal:  Pediatrics       Date:  2011-10-16       Impact factor: 7.124

4.  Pediatricians' attitudes and practices on ADHD before and after the development of ADHD pediatric practice guidelines.

Authors:  Mark L Wolraich; David E Bard; Martin T Stein; Jerry L Rushton; Karen G O'Connor
Journal:  J Atten Disord       Date:  2009-08-25       Impact factor: 3.256

5.  Fragmented care for inner-city minority children with attention-deficit/hyperactivity disorder.

Authors:  James P Guevara; Chris Feudtner; Daniel Romer; Thomas Power; Ricardo Eiraldi; Snejana Nihtianova; Aracely Rosales; Janet Ohene-Frempong; Donald F Schwarz
Journal:  Pediatrics       Date:  2005-10       Impact factor: 7.124

6.  Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder.

Authors: 
Journal:  Pediatrics       Date:  2001-10       Impact factor: 7.124

7.  Race/ethnicity and insurance status as factors associated with ADHD treatment patterns.

Authors:  Jack Stevens; Jeffrey S Harman; Kelly J Kelleher
Journal:  J Child Adolesc Psychopharmacol       Date:  2005-02       Impact factor: 2.576

8.  Use of practice guidelines in the primary care of children with attention-deficit/hyperactivity disorder.

Authors:  Jerry L Rushton; Kathryn E Fant; Sarah J Clark
Journal:  Pediatrics       Date:  2004-07       Impact factor: 7.124

9.  Implementing the American Academy of Pediatrics attention-deficit/hyperactivity disorder diagnostic guidelines in primary care settings.

Authors:  Laurel K Leslie; Jill Weckerly; Dena Plemmons; John Landsverk; Sarita Eastman
Journal:  Pediatrics       Date:  2004-07       Impact factor: 7.124

10.  The myADHDportal.com Improvement Program: An innovative quality improvement intervention for improving the quality of ADHD care among community-based pediatricians.

Authors:  Jeffery N Epstein; Joshua M Langberg; Philip K Lichtenstein; Rebecca Kolb; John O Simon
Journal:  Clin Pract Pediatr Psychol       Date:  2013-03-01
View more
  36 in total

1.  Contextual variability of ADHD symptoms: embracement not erasement of a key moderating factor.

Authors:  Nanda Rommelse; Tessa Bunte; Walter Matthys; Erica Anderson; Jan Buitelaar; Lauren Wakschlag
Journal:  Eur Child Adolesc Psychiatry       Date:  2015-01       Impact factor: 4.785

2.  Predictors of Medication Continuity in Children With ADHD.

Authors:  William B Brinkman; Heidi Sucharew; Jessica Hartl Majcher; Jeffery N Epstein
Journal:  Pediatrics       Date:  2018-06       Impact factor: 7.124

3.  Primary Care Management of Children with Attention-Deficit/Hyperactivity Disorder Appears More Assertive Following Brief Psychiatric Intervention Compared with Single Session Consultation.

Authors:  Carol M Rockhill; L Lee Carlisle; Pingping Qu; Ann Vander Stoep; William French; Chuan Zhou; Kathleen Myers
Journal:  J Child Adolesc Psychopharmacol       Date:  2020-03-11       Impact factor: 2.576

4.  Parent-Reported Health Consequences and Relationship to Expenditures in Children with ADHD.

Authors:  Neal A deJong; Christianna S Williams; Kathleen C Thomas
Journal:  Matern Child Health J       Date:  2016-04

5.  Variations in Mental Health Diagnosis and Prescribing Across Pediatric Primary Care Practices.

Authors:  Stephanie L Mayne; Michelle E Ross; Lihai Song; Banita McCarn; Jennifer Steffes; Weiwei Liu; Benyamin Margolis; Romuladus Azuine; Edward Gotlieb; Robert W Grundmeier; Laurel K Leslie; Russell Localio; Richard Wasserman; Alexander G Fiks
Journal:  Pediatrics       Date:  2016-04-01       Impact factor: 7.124

6.  Prescription Drug Use and Cost Trends Among Medicaid-Enrolled Children with Disruptive Behavioral Disorders.

Authors:  Lirong Zhao; Caitlin Cross-Barnet; Vetisha L McClair
Journal:  J Behav Health Serv Res       Date:  2018-10       Impact factor: 1.505

Review 7.  National Child Mental Health Quality Measures: Adherence Rates and Extent of Evidence for Clinical Validity.

Authors:  Bonnie T Zima; Juliet B Edgcomb; Samantha A Shugarman
Journal:  Curr Psychiatry Rep       Date:  2019-01-31       Impact factor: 5.285

8.  Preschool ADHD Diagnosis and Stimulant Use Before and After the 2011 AAP Practice Guideline.

Authors:  Alexander G Fiks; Michelle E Ross; Stephanie L Mayne; Lihai Song; Weiwei Liu; Jennifer Steffes; Banita McCarn; Robert W Grundmeier; A Russell Localio; Richard Wasserman
Journal:  Pediatrics       Date:  2016-11-15       Impact factor: 7.124

9.  Impact of a Web-Portal Intervention on Community ADHD Care and Outcomes.

Authors:  Jeffery N Epstein; Kelly J Kelleher; Rebecca Baum; William B Brinkman; James Peugh; William Gardner; Phil Lichtenstein; Joshua M Langberg
Journal:  Pediatrics       Date:  2016-08       Impact factor: 7.124

Review 10.  Impact of Attention-Deficit Hyperactivity Disorder on School Performance: What are the Effects of Medication?

Authors:  Raman Baweja; Richard E Mattison; James G Waxmonsky
Journal:  Paediatr Drugs       Date:  2015-12       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.